Eye Care in China

Date: October 11, 2017
Pages: 17
Price:
US$ 990.00
Publisher: Euromonitor International Ltd
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: ECB2A494EB0EN
Leaflet:

Download PDF Leaflet

According to the China Food and Drug Administration (CFDA), Hypromellose eye drops were switched from Rx to OTC status at the end of 2016. This ingredient is poised to become a growth engine in standard eye care over the forecast period as many new brands have entered the category.

Euromonitor International's Eye Care in China report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2012-2016, allowing you to identify the sectors driving growth. Forecasts to 2021 illustrate how the market is set to change.

Product coverage: Allergy Eye Care, Standard Eye Care.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Eye Care market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Headlines
Prospects
New Ingredient Drives Value Growth
Drops Remain the Most Prevalent Format in Standard Eye Care
Slower Growth Expected Due To Intensifying Competition From Contact Lens Care and Growing Concerns About Preservatives
Competitive Landscape
Chemical-based Eye Drops Continue To Lead Standard Eye Care
Grand Pharma (china) Co Ltd Continues To Record Strong Growth
Category Data
  Table 1 Sales of Eye Care by Category: Value 2012-2017
  Table 2 Sales of Eye Care by Category: % Value Growth 2012-2017
  Table 3 Sales of Standard Eye Care by Format: % Value 2012-2017
  Table 4 Sales of Standard Eye Care by Positioning: % Value 2012-2017
  Table 5 NBO Company Shares of Eye Care: % Value 2013-2017
  Table 6 LBN Brand Shares of Eye Care: % Value 2014-2017
  Table 7 Forecast Sales of Eye Care by Category: Value 2017-2022
  Table 8 Forecast Sales of Eye Care by Category: % Value Growth 2017-2022
Executive Summary
Consumer Health Continues To Perform Well
Healthcare Reform Policies Heavily Impact the Industry
Mergers and Acquisitions Reshape the Competitive Landscape
Omni-channel Distribution Is Emerging in Consumer Health
Stable Growth Anticipated
Market Indicators
  Table 9 Consumer Expenditure on Health Goods and Medical Services: Value 2012-2017
  Table 10 Life Expectancy at Birth 2012-2017
Market Data
  Table 11 Sales of Consumer Health by Category: Value 2012-2017
  Table 12 Sales of Consumer Health by Category: % Value Growth 2012-2017
  Table 13 NBO Company Shares of Consumer Health: % Value 2013-2017
  Table 14 LBN Brand Shares of Consumer Health: % Value 2014-2017
  Table 15 Distribution of Consumer Health by Format: % Value 2012-2017
  Table 16 Distribution of Consumer Health by Format and Category: % Value 2017
  Table 17 Forecast Sales of Consumer Health by Category: Value 2017-2022
  Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2017-2022
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
  Summary 1 OTC: Switches 2016-2017
Definitions
Sources
  Summary 2 Research Sources
Skip to top


Eye Care - Hong Kong, China US$ 900.00 Mar, 2011 · 24 pages
Eye Care in Lithuania US$ 990.00 Apr, 2013 · 22 pages
Eye Care in Macedonia US$ 990.00 Jul, 2013 · 22 pages
Eye Care in Mexico US$ 990.00 Oct, 2017 · 19 pages

Ask Your Question

Eye Care in China
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: